Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 May;18(5):1047-1066.
doi: 10.1002/alz.12644. Epub 2022 Mar 17.

Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis

Lucia Crivelli et al. Alzheimers Dement. 2022 May.

Abstract

Introduction: We conducted a systematic review and meta-analysis of the cognitive effects of coronavirus disease 2019 (COVID-19) in adults with no prior history of cognitive impairment.

Methods: Searches in Medline/Web of Science/Embase from January 1, 2020, to December 13, 2021, were performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A meta-analysis of the Montreal Cognitive Assessment (MoCA) total score comparing recovered COVID-19 and healthy controls was performed.

Results: Oof 6202 articles, 27 studies with 2049 individuals were included (mean age = 56.05 years, evaluation time ranged from the acute phase to 7 months post-infection). Impairment in executive functions, attention, and memory were found in post-COVID-19 patients. The meta-analysis was performed with a subgroup of 290 individuals and showed a difference in MoCA score between post-COVID-19 patients versus controls (mean difference = -0.94, 95% confidence interval [CI] -1.59, -0.29; P = .0049).

Discussion: Patients recovered from COVID-19 have lower general cognition compared to healthy controls up to 7 months post-infection.

Keywords: COVID-19; SARS-CoV-2 coronavirus; attention; cognition; cognitive dysfunction; executive functions; neuropsychological test.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
PRISMA flow chart describing the screening and selection of articles
FIGURE 2
FIGURE 2
MoCA meta‐analysis forest plot
FIGURE 3
FIGURE 3
Influential Assessment
FIGURE 4
FIGURE 4
MoCA meta‐analysis publication bias
FIGURE 5
FIGURE 5
Meta‐regression Model: MoCA by age

Comment in

References

    1. Al‐Aly Z, Xie Y, Bowe B. High‐dimensional characterization of post‐acute sequelae of COVID‐19. Nature. 2021;594(7862):259‐264. - PubMed
    1. Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017;140(8):2246‐2251. - PubMed
    1. Verstrepen K, Baisier L, De Cauwer H. Neurological manifestations of COVID‐19, SARS and MERS. Acta Neurol Belg. 2020;120(5):1051‐1060. - PMC - PubMed
    1. Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415‐424. - PMC - PubMed
    1. Saracli O, Akca AS, Atasoy N, et al. The Relationship between Quality of Life and Cognitive Functions, Anxiety and Depression among Hospitalized Elderly Patients. Clin Psychopharmacol Neurosci. 2015;13(2):194‐200. - PMC - PubMed